Status:
COMPLETED
Patient Journey Application for Discontinuing Inappropriate PPI Use: a Randomized Controlled Trial
Lead Sponsor:
Radboud University Medical Center
Conditions:
Proton Pump Inhibitor
Inappropriate Drug Use
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Rationale/objective: This study hypothesizes that offering patient-tailored and dosed information on PPI discontinuation in patients with inappropriate chronic PPI use will result in an increased disc...
Eligibility Criteria
Inclusion
- Patients with daily PPI use for at least 4 weeks;
- Age 18-70 years.
Exclusion
- Chronic PPI indication according to NHG-guidelines;
- Chronic PPI indication according to treating physician, despite absence of chronic PPI indication according to NHG-guidelines;
- Patients that underwent anti-reflux surgery;
- No understanding of the study or study procedures including the digital application (smartphone/computer skills);
- No smartphone/computer available;
- No informed consent;
- Limited life span.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 11 2023
Estimated Enrollment :
163 Patients enrolled
Trial Details
Trial ID
NCT05348252
Start Date
May 1 2022
End Date
July 11 2023
Last Update
November 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud university medical center
Nijmegen, Gelderland, Netherlands